FIELD: organic chemistry. SUBSTANCE: invention describes the crystalline form of trovafloxacine zwitterion of the formula (I) and method of its preparing. Compounds can be used for treatment of mammals with bacterial infections. EFFECT: improved method of preparing. 8 cl
Authors
Dates
2000-01-27—Published
1996-07-29—Filed